| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| adar1 inhibitor clinical trial | 1.91 | 0.9 | 7293 | 52 | 30 |
| adar1 | 1.47 | 0.7 | 8809 | 84 | 5 |
| inhibitor | 1.39 | 0.8 | 1238 | 72 | 9 |
| clinical | 0.29 | 0.9 | 621 | 46 | 8 |
| trial | 0.36 | 0.6 | 8129 | 93 | 5 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| adar1 inhibitor clinical trial | 1.28 | 0.4 | 4151 | 47 |
| ddr1 inhibitor clinical trial | 1.39 | 0.8 | 8095 | 89 |
| anti-adar1 role in cancer | 1.59 | 0.4 | 4562 | 14 |
| anti-adar1 mechanism of action | 1.72 | 0.8 | 2334 | 84 |
| rad51 inhibitor clinical trial | 1.63 | 0.5 | 212 | 87 |
| anti adar1 polyclonal antibody | 0.52 | 0.4 | 2834 | 86 |
| atr inhibitor clinical trial | 0.88 | 0.1 | 4855 | 68 |
| adar1 affect gene expression | 0.7 | 0.5 | 6800 | 81 |
| ccr2 inhibitor clinical trial | 0.1 | 0.9 | 9753 | 21 |
| a2a inhibitor clinical trial | 1.35 | 0.4 | 7397 | 50 |
| rac1 inhibitor clinical trial | 1.07 | 0.5 | 4355 | 52 |
| adar1 masks the cancer immunotherapeutic | 1.76 | 0.7 | 4498 | 32 |
| adar1 co-immunoprecipitation | 0.49 | 0.7 | 7680 | 4 |
| substrate recognition by adar1 and adar2 | 0.92 | 0.9 | 9753 | 87 |
| what is adar ii | 0.24 | 0.4 | 3449 | 46 |
| adar1 r-loop | 1.31 | 0.6 | 3159 | 3 |
| adar 1 and adar 2 | 0.38 | 0.2 | 9903 | 24 |
| adar1-dsrna-mda5 | 1.05 | 0.9 | 8109 | 47 |
| adar1-p150 | 1.56 | 0.6 | 9155 | 97 |
